PRESS RELEASES

Nyxoah files Registration Statement for Proposed Initial Public Offering in the United States

Nyxoah files Registration Statement for Proposed Initial Public Offering in the United States

Mont-Saint-Guibert, Belgium – June 10, 2021, 11:30pm CET / 5:30pm ET – Nyxoah SA (Euronext Brussels: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company has publicly filed a registration statement on Form F-1 with the U.S. Securities and Exchange Commission (the “SEC”) relating to a proposed initial public offering of its ordinary shares, which are expected to be listed on the NASDAQ Global Market in the United States.  The number of ordinary shares to be offered and the price for the proposed offering have not yet been determined.

Nyxoah’s ordinary shares are currently listed on Euronext Brussels under the symbol “NYXH”. An application has been made to list the ordinary shares on the NASDAQ Global Market under the same symbol.

Piper Sandler, Stifel and Cantor are acting as joint book-running managers for the proposed offering. Degroof Petercam is acting as a manager.

A registration statement on Form F-1 has been filed with the SEC but has not yet become effective. The ordinary shares may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective. This press release does not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification or publication of an offering prospectus under the securities laws of any such state or jurisdiction.

The proposed offering of ordinary shares in the United States will be made only by means of a prospectus. When available, copies of the preliminary prospectus relating to the proposed offering can be obtained from Piper Sandler & Co., Attention: Prospectus Department, 800 Nicollet Mall, J12S03, Minneapolis, Minnesota 55402, by e-mail at [email protected], or by phone at (800) 747-3924; Stifel, Nicolaus & Company, Incorporated at Attention: Syndicate, One Montgomery Street, Suite 3700, San Francisco, CA 94104, by telephone at (415) 364-2720, or by email at [email protected]; or Cantor Fitzgerald & Co., Attention: Capital Markets, 499 Park Avenue, 4th Floor, New York, New York 10022; email: [email protected].

Contacts:

Nyxoah
Fabian Suarez, Chief Financial Officer
[email protected]
+32 10 22 24 55

Gilmartin Group
Vivian Cervantes
[email protected]com

Attachment

Latest News

Top liver disease conference showcases positive clinical data from Yaqrit’s technologies

Top liver disease conference showcases positive clinical data from Yaqrit’s technologies Results from two trials presented at EASL1 International Liver Conference 2021 show benefits for patients with liver failure and those with advanced cirrhosis London, UK, 24 June, 2021 – New treatments for liver disease patients have been given top billing at this week’s International Liver Congress (ILC), one of the biggest global meetings for liver doctors and researchers, […]

Colliers launches strategic partnership with Blue Skyre to bolster innovative Facilities Management Advisory offering

Blue Skyre brings deep facilities management expertise to meet client needs ATLANTA, June 24, 2021 (GLOBE NEWSWIRE) — Leading diversified professional services and investment management company Colliers (NASDAQ and TSX: CIGI) today announced a global partnership with Blue Skyre IBE, LLC (“Blue Skyre”) to accelerate the growth of an innovative Facilities Management (“FM”) Advisory offering. […]